GW&K Investment Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $15.1M | Buy |
|
|||||
|
2025
Q2 | $13.4M | Sell |
|
|||||
|
2025
Q1 | $13.3M | Buy |
|
|||||
|
2024
Q4 | $11.6M | Buy |
|
|||||
|
2024
Q3 | $11.8M | Buy |
|
|||||
|
2024
Q2 | $12.1M | Buy |
|
|||||
|
2024
Q1 | $14.8M | Sell |
|
|||||
|
2023
Q4 | $13.1M | Buy |
|
|||||
|
2023
Q3 | $8.96M | Buy |
|
|||||
|
2023
Q2 | $6.08M | Buy |
|
|||||
|
2023
Q1 | $5.64M | Buy |
|
|||||
|
2022
Q4 | $5.27M | Buy |
|
|||||
|
2022
Q3 | $2.04M | Sell |
|
|||||
|
2022
Q2 | $2.32M | Sell |
|
|||||
|
2022
Q1 | $3.22M | Sell |
|
|||||
|
2021
Q4 | $4.37M | Sell |
|
|||||
|
2021
Q3 | $6.32M | Sell |
|
|||||
|
2021
Q2 | $5.69M | Sell |
|
|||||
|
2021
Q1 | $7.04M | Sell |
|
|||||
|
2020
Q4 | $7M | Sell |
|
|||||
|
2020
Q3 | $8.75M | Sell |
|
|||||
|
2020
Q2 | $7.09M | Buy |
|
|||||
|
2020
Q1 | $4.78M | Sell |
|
|||||
|
2019
Q4 | $7.01M | Sell |
|
|||||
|
2019
Q3 | $6.48M | Sell |
|
|||||
|
2019
Q2 | $7.31M | Buy |
|